Jurkiewicz A, Jurkiewicz N H
Br J Pharmacol. 1976 Feb;56(2):169-78. doi: 10.1111/j.1476-5381.1976.tb07439.x.
1 In rat isolated vas deferens, the isotonic contractile responses to low doses of noradrenaline or adrenaline were antagonized, and those to high doses were potentiated, by yohimbine, piperoxan, phentolamine and tolazoline. Effects due to intermediate doses were not affected, or were potentiated within about 30 min, following an initial inhibition. 2 The alpha-adrenoceptor blockers thus caused a shift to the right and an increase of the maximum height of log dose-response curves of alpha-adrenoceptor stimulants. For a given dose of antagonist, the onset was slower for the potentiating than for the blocking effect. 3 The shift to the right induced by piperoxan and yohimbine on dose-response curves of noradrenaline and adrenaline was analysed with the Schild plot, and the slopes obtained, around 0.3, were lower than expected from receptor theory. When cocaine was used to block neuronal uptake, the slopes were close to 1.0. 4 The increase in maximum response to noradrenaline and adrenaline induced by alpha-adrenoceptor blockers was dependent on the time of incubation, on the dose of antagonist, and on the initial height of responses to the agonist. A less pronounced potentiation was also obtained when acetylcholine was used as agonist. 5 The findings are explained in terms of receptor theory as being due to a dual effect of alpha-adrenoceptor antagonists; competitive antagonism proper, which may be disclosed after blockade of neuronal uptake, and an interaction at a different locus, which results in potentiation of the effects of noradrenaline and adrenaline.
1 在大鼠离体输精管中,育亨宾、哌罗克生、酚妥拉明和妥拉唑啉可拮抗低剂量去甲肾上腺素或肾上腺素引起的等张收缩反应,而对高剂量则起增强作用。中等剂量引起的效应在最初受到抑制后,约30分钟内不受影响或增强。2 因此,α-肾上腺素受体阻滞剂使α-肾上腺素受体激动剂的对数剂量-反应曲线向右移动并使最大高度增加。对于给定剂量的拮抗剂,增强作用的起效比阻断作用慢。3 用Schild图分析哌罗克生和育亨宾对去甲肾上腺素和肾上腺素剂量-反应曲线的向右移动,得到的斜率约为0.3,低于受体理论预期。当用可卡因阻断神经元摄取时,斜率接近1.0。4 α-肾上腺素受体阻滞剂引起的对去甲肾上腺素和肾上腺素最大反应的增加取决于孵育时间、拮抗剂剂量以及对激动剂反应的初始高度。当使用乙酰胆碱作为激动剂时,也获得较不明显的增强作用。5 根据受体理论,这些发现被解释为α-肾上腺素受体拮抗剂的双重作用所致;适当的竞争性拮抗作用,在阻断神经元摄取后可能显现,以及在不同位点的相互作用,导致去甲肾上腺素和肾上腺素的作用增强。